Skip Nav Destination
First Edition
Research Article October 8 2024
Failure of metabolic checkpoint control during late-stage granulopoiesis drives neutropenia in reticular dysgenesis
Review Article October 7 2024
How I use Maintenance Therapy in Acute Myeloid Leukemia
Review Article October 7 2024
How I treat Blastic Plasmacytoid Dendritic Cell Neoplasm
Research Article October 7 2024
Follicular lymphoma comprises germinal center-like and memory-like molecular subtypes with prognostic significance
Research Article October 7 2024
Single-cell analysis of the multiple myeloma microenvironment after gamma-secretase inhibition and CAR T-cell therapy
Research Article October 7 2024
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia
Research Article October 4 2024
Safety and Efficacy of Standard of Care Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma
Surbhi Sidana,Krina K. Patel,Lauren C Peres,Radhika Bansal,Mehmet Hakan Kocoglu,Leyla Shune,Shebli Atrash,Kinaya Smith,Shonali Midha,Christopher J Ferreri,Binod Dhakal,Danai Dima,Patrick Costello,Charlotte Wagner,Ran Reshef,Hitomi Hosoya,Lekha Mikkilineni,Djordje Atanackovic,Saurabh Chhabra,Ricardo D Parrondo,Omar Nadeem,Hashim Mann,Nilesh Kalariya,Vanna Hovanky,Gabriel DeAvila,Ciara L Freeman,Frederick L Locke,Melissa Alsina,Sandy Wong,Megan M Herr,Myo Htut,Joseph P. McGuirk,Douglas W Sborov,Jack Khouri,Thomas Martin,Murali Janakiram,Yi Lin,Doris K Hansen
Review Article October 2 2024
How I Treat: Secondary Acute Myeloid Leukemia
Review Article October 2 2024
How I Treat Sickle Cell Disease with Gene Therapy
Review Article October 2 2024
How I Treat Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Review Article October 2 2024
Platelet generation in vivo and in vitro
Research Article October 2 2024
Ex Vivo Venetoclax Sensitivity Predicts Clinical Response in Acute Myeloid Leukemia in the Prospective VenEx Trial
Sari Kytölä,Ida Maria Vänttinen,Tanja Ruokoranta,Anu Partanen,Annasofia Holopainen,Joseph Saad,Milla E.L. Kuusisto,Sirpa Koskela,Riikka Katariina Räty,Maija Itälä-Remes,Imre Västrik,Minna Suvela,Alun Owen Parsons,Kimmo Porkka,Krister Wennerberg,Caroline A. Heckman,Tero Jalkanen,Teppo Huttunen,Pia Ettala, MD,Johanna Rimpiläinen,Timo Siitonen,Marja Pyörälä,Heikki Kuusanmäki,Mika Kontro
Research Article October 2 2024
Complement Biosensors Identify a Classical Pathway Stimulus in Complement-Mediated Thrombotic Microangiopathy
Letter October 1 2024
High-dose IV ascorbic acid therapy in CCUS patients with TET2 mutations
Research Article September 27 2024
Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study
Ashraf Z Badros,Laahn Foster,Larry D. Anderson, Jr.,Chakra P. Chaulagain,Erin M Pettijohn,Andrew J Cowan,Caitlin L. Costello,Sarah Larson,Douglas W Sborov,Kenneth H Shain,Rebecca Silbermann,Nina Shah,Alfred Chung,Maria Krevvata,Huiling Pei,Sharmila Patel,Vipin Khare,Annelore Cortoos,Robin Carson,Thomas Lin,Peter M Voorhees
Research Article September 25 2024
Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis
Research Article September 25 2024
Impact of soluble BCMA and non-T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma
Research Article September 24 2024
Disruption of cotranscriptional splicing suggests that RBM39 is a therapeutic target in acute lymphoblastic leukemia
Qi Jin,Ethan Harris,Jacquelyn A Myers,Rashid Mehmood,Anitria Cotton,Hazheen K Shirnekhi,David W Baggett,Jeremy Qiang Wen,Andrew B Schild,Rahul S Bhansali,Jonathon Klein,Shilpa Narina,Tim Pieters,Akihide. Yoshimi,Shondra M Pruett-Miller,Richard Kriwacki,Omar Abdel-Wahab,Sebastien Malinge,Panagiotis Ntziachristos,Esther A Obeng,John D. Crispino
Research Article September 24 2024
Outcomes in patients with ETV6::RUNX1 or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV/XVI studies
Research Article September 24 2024
Recurrent CLTC::SYK fusions and CSF1R mutations in juvenile xanthogranuloma of soft tissue
Paul G Kemps,Hans J Baelde,Ruben Harmen Paul Vorderman,Ellen Stelloo,Joost F Swennenhuis,Karoly Szuhai,Meindert H Lamers,Boyd Kenkhuis,Maysa Al-Hussaini,Inge Briaire-de Bruijn,Suk Wai Lam,Judith V.M.G. Bovee,Arjen HG Cleven,Robert M. Verdijk,Carel J.M. van Noesel,Marijke van Dijk,Marijn A. Scheijde-Vermeulen,Annette H Bruggink,Jan AM van Laar,Andrica C.H. de Vries,Wim Tissing,Cor van den Bos,Andreas von Deimling,Tom van Wezel,Astrid G.S. van Halteren,Pancras C.W. Hogendoorn
Letter September 24 2024
Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia
Research Article September 24 2024
Sustained Benefit of Zanubrutinib vs Ibrutinib in Patients With R/R CLL/SLL: Final Comparative Analysis of ALPINE
Jennifer R. Brown,Barbara Eichhorst,Nicole Lamanna,Susan M O'Brien, M.D.,Constantine S. Tam,Lugui Qiu,Wojciech Jurczak,Keshu Zhou,Martin Šimkovič,Jiří Mayer,Amanda Gillespie-Twardy,Alessandra Ferrajoli,Peter Stephen Ganly,Robert Weinkove,Sebastian Grosicki,Andrzej Mital,Tadeusz Robak, Prof.,Anders Osterborg,Habte A. Yimer,Megan (Der Yu) Wang,Tommi Salmi,Liping Wang,Jessica Li,Kenneth Wu,Aileen Cleary Cohen,Mazyar Shadman
Review Article September 24 2024
The present and future for CAR-T cell therapy in adult B-cell ALL
Review Article September 24 2024
The current landscape of frontline large B-cell lymphoma trials
Review Article September 24 2024
How I Treat patients with AML using azacitidine and venetoclax
Research Article September 24 2024
Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia
Sunniyat Rahman,Gianna Bloye,Nadine Farah,Jonas Demeulemeester,Joana R Costa,David O'Connor,Rachael Pocock,Tanya Rapoz-D'Silva,Adam Turna,Lingyi Wang,Soo Wah Lee,Adele K Fielding,Juliette Roels,Roman Jaksik,Małgorzata Dawidowska,Pieter Van Vlierberghe,Suzana Hadjur,Jim R Hughes,James Davies,Alejandro Gutierrez,Michelle Kelliher,Peter Van Loo,Mark A. Dawson,Marc R. Mansour
Research Article September 24 2024
Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescuing and cancer mutations
Fernanda Gutierrez-Rodrigues,Emma M Groarke,Natthakan Thongon,Juan Jose Rodriguez-Sevilla,Luiz Fernando Bazzo Catto,Marena Rebekka Niewisch,Ruba N Shalhoub,Lisa J. McReynolds,Diego V Clé,Bhavisha A. Patel,Xiaoyang Ma,Dalton Hironaka,Flavia S Donaires,Nina R Spitofsky,Barbara A. Santana,Tsung-Po Lai,Lemlem Alemu,Sachiko Kajigaya,Ivana Darden,Weiyin Zhou,Paul V. Browne,Subrata Paul,Justin Lack,David J. Young,Courtney D. DiNardo,Abraham Aviv,Feiyang Ma,Michel Michels de Oliveira,Ana Paula de Azambuja,Cynthia E. Dunbar,Malgorzata Olszewska,Emmanuel Olivier,Eirini P Papapetrou,Neelam Giri,Blanche P. Alter,Carmem M.S. Bonfim,Colin O. Wu,Guillermo Garcia-Manero,Sharon A Savage,Neal S. Young,Simona Colla,Rodrigo T. Calado
Letter September 24 2024
A Weekly Low-Dose Regimen of Decitabine and Venetoclax is Efficacious and Less Myelotoxic in a Racially Diverse Cohort
Mendel Goldfinger,Ioannis Mantzaris,Aditi Shastri,Yogen Saunthararajah,Kira Gritsman,Alejandro Sica,Noah Kornblum,Nishi Shah,David Levitz,Bradley Rockwell,Lauren C Shapiro,Ridhi Gupta,Kith Pradhan,Xiaonan Xue,Anne Munoz,Aradhika Dhawan,Karen Fehn,Monica Comas,Jhannine Alyssa Verceles,Brian A. Jonas,Suman Kambhampati,Yang Shi,Ira Braunschweig,Dennis L Cooper,Marina Y. Konopleva,Eric J Feldman,Amit Verma
Review Article September 18 2024
Management of iron overload: lessons from transfusion-dependent hemoglobinopathies
Brief Report September 18 2024
Measurable Residual Disease by Mass Spectrometry and Next-Generation Flow to Assess Treatment Response in Myeloma
Noemi Puig,Cristina Agullo Roca,Teresa Contreras Sanfeliciano,M Teresa Cedena,Joaquín Martínez-López,Albert Oriol,María-Jesús Blanchard,Rafael Ríos-Tamayo,Belén Iñigo Rodríguez,Anna Sureda,Sunil Lakhwani,Javier de la Rubia Comos,Veronica Gonzalez-Calle,Valentín Cabañas,Luis Palomera,José María M Moraleda,Joan Bargay,Sergio Castro,Laura Rosiñol,Joan Bladé,Jesús F. San-Miguel,Juan-Jose Lahuerta,Bruno Paiva,Maria-Victoria Mateos
Research Article September 10 2024
Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPN
Edimara Reis,Rebecca Buonpane,Hamza Celik,Caroline Marty,Angela Lei,Fatoumata Jobe,Mark Rupar,Yue Zhang,Darlise DiMatteo,Rahel Awdew,Bianca L Ferreira,Lynn Leffet,Lu Lu,Elodie Rosa,Maxime Evrard,Gaurang Trivedi,Brittney Wass,April Horsey,Xin He,Maryanne B Covington,Alla Volgina,Florence Pasquier,Laurence Legros,Guillemette Fouquet,William Vainchenker,Yan-ou Yang,Breann Barker,Jing Zhou,Shaun Stewart,Ian S Hitchcock,Dashyant Dhanak,Ricardo Macarron,Isabelle Plo,Horacio G Nastri,Patrick A Mayes
Research Article September 6 2024
Baseline Immune State and T-cell Clonal Kinetics are Associated with Durable Response to CAR-T Therapy in Large B-cell Lymphoma
Katie Maurer,Isabella N Grabski,Roch Houot,Satyen H. Gohil,Shogo Miura,Robert A Redd,Haoxiang Lyu,Wesley Lu,Yohei Arihara,Justin Budka,Mikaela McDonough,Michela Ansuinelli,Carol G Reynolds,Heather Jacene,Shuqiang Li,Kenneth J Livak,Jerome Ritz,Brodie Miles,Mike Mattie,Donna S. Neuberg,Rafael A. Irizarry,Philippe Armand,Catherine J Wu,Caron A. Jacobson
Review Article September 5 2024
TP53-Mutated Acute Myeloid Leukemia: How Can We Improve Outcomes?
Research Article August 28 2024
Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses
Sikander Ailawadhi,Bertrand Arnulf,Krina K. Patel,Michele Cavo,Ajay K. Nooka,Salomon Manier,Natalie S Callander,Luciano J. Costa,Ravi Vij,Nizar J. Bahlis,Philippe Moreau,Scott R. Solomon,Ingerid Weum Abrahamsen,Rachid C Baz,Annemiek Broijl,Christine Chen,Sundar Jagannath,Noopur Raje,Christof Scheid,Michel Delforge,Reuben Benjamin,Thomas Pabst,Shinsuke Iida,Jesus G. Berdeja,Sergio A Giralt,Anna Truppel-Hartmann,Yanping Chen,Xiaobo Zhong,Fan Wu,Julia Piasecki,Laurie Eliason,Devender S. Dhanda,Jasper Felten,Andrea Caia,Mark Cook,Mihaela Popa-Mckiver,Paula Rodriguez-Otero
Research Article August 28 2024
Prognostic impact of cytogenetic abnormalities by FISH in AL amyloidosis with daratumumab-based frontline therapy
Research Article August 27 2024
Antimetabolite Dose Intensity and Adverse Outcomes in Children with Acute Lymphoblastic Leukemia: A COG-AALL03N1 Report
Review Article August 20 2024
How I treat adult Ph-positive ALL
Research Article August 20 2024
Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies
Cyrille Touzeau,Amrita Y Krishnan,Philippe Moreau,Aurore Perrot,Saad Z Usmani,Salomon Manier,Michele Cavo,Carmen Martinez Chamorro,Ajay K. Nooka,Thomas G Martin,Lionel Karlin,Xavier Leleu,Nizar J. Bahlis,Britta Besemer,Lixia Pei,Sarah Stein,Shun Xin Wang Lin,Danielle Trancucci,Raluca Verona,Suzette Girgis,Xin Miao,Clarissa Uhlar,Katherine Chastain,Alfred Garfall
Review Article August 16 2024
How I approach intersectionality in hematopoietic stem cell transplantation
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
